Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature

Blood. 2023 Jun 15;141(24):2955-2960. doi: 10.1182/blood.2022016587.

Abstract

The chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereotyped B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a whole-genome chromatin profiling of histone 3 lysine 27 acetylation of 22 CLLs from major subsets, which were compared against nonstereotyped CLLs and normal B-cell subpopulations. Although subsets 1, 2, and 4 did not differ much from their nonstereotyped CLL counterparts, subset 8 displayed a remarkably distinct chromatin activation profile. In particular, we identified 209 de novo active regulatory elements in this subset, which showed similar patterns with U-CLLs undergoing Richter transformation. These regions were enriched for binding sites of 9 overexpressed transcription factors. In 78 of 209 regions, we identified 113 candidate overexpressed target genes, 11 regions being associated with more than 2 adjacent genes. These included blocks of up to 7 genes, suggesting local coupregulation within the same genome compartment. Our findings further underscore the uniqueness of subset 8 CLL, notable for the highest risk of Richter's transformation among all CLLs and provide additional clues to decipher the molecular basis of its clinical behavior.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes
  • Chromatin / genetics
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Lymphoma, Large B-Cell, Diffuse*
  • Receptors, Antigen, B-Cell / genetics

Substances

  • Chromatin
  • Receptors, Antigen, B-Cell